Logo image of TOM2.AS

TOMTOM NV (TOM2.AS) Stock Fundamental Analysis

Europe - AMS:TOM2 - NL0013332471 - Common Stock

5.455 EUR
-0.1 (-1.8%)
Last: 9/19/2025, 7:00:00 PM
Fundamental Rating

3

Overall TOM2 gets a fundamental rating of 3 out of 10. We evaluated TOM2 against 103 industry peers in the Software industry. The financial health of TOM2 is average, but there are quite some concerns on its profitability. TOM2 has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year TOM2 has reported negative net income.
TOM2 had a positive operating cash flow in the past year.
TOM2 had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: TOM2 reported negative operating cash flow in multiple years.
TOM2.AS Yearly Net Income VS EBIT VS OCF VS FCFTOM2.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

1.2 Ratios

The Return On Assets of TOM2 (-4.35%) is worse than 66.99% of its industry peers.
TOM2's Return On Equity of -25.67% is on the low side compared to the rest of the industry. TOM2 is outperformed by 73.79% of its industry peers.
TOM2's Return On Invested Capital of 0.12% is in line compared to the rest of the industry. TOM2 outperforms 44.66% of its industry peers.
Industry RankSector Rank
ROA -4.35%
ROE -25.67%
ROIC 0.12%
ROA(3y)-5.92%
ROA(5y)-10.94%
ROE(3y)-25.16%
ROE(5y)-35.09%
ROIC(3y)N/A
ROIC(5y)N/A
TOM2.AS Yearly ROA, ROE, ROICTOM2.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

Looking at the Operating Margin, with a value of 0.13%, TOM2 is in line with its industry, outperforming 43.69% of the companies in the same industry.
TOM2 has a better Gross Margin (87.37%) than 84.47% of its industry peers.
In the last couple of years the Gross Margin of TOM2 has grown nicely.
Industry RankSector Rank
OM 0.13%
PM (TTM) N/A
GM 87.37%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.86%
GM growth 5Y2.76%
TOM2.AS Yearly Profit, Operating, Gross MarginsTOM2.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TOM2 is destroying value.
TOM2 has less shares outstanding than it did 1 year ago.
TOM2 has less shares outstanding than it did 5 years ago.
The debt/assets ratio for TOM2 is higher compared to a year ago.
TOM2.AS Yearly Shares OutstandingTOM2.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
TOM2.AS Yearly Total Debt VS Total AssetsTOM2.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

TOM2 has an Altman-Z score of 1.36. This is a bad value and indicates that TOM2 is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of TOM2 (1.36) is worse than 69.90% of its industry peers.
TOM2 has a debt to FCF ratio of 1.98. This is a very positive value and a sign of high solvency as it would only need 1.98 years to pay back of all of its debts.
TOM2 has a Debt to FCF ratio of 1.98. This is in the better half of the industry: TOM2 outperforms 66.02% of its industry peers.
A Debt/Equity ratio of 0.27 indicates that TOM2 is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.27, TOM2 is in line with its industry, outperforming 55.34% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 1.98
Altman-Z 1.36
ROIC/WACC0.02
WACC7.55%
TOM2.AS Yearly LT Debt VS Equity VS FCFTOM2.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

TOM2 has a Current Ratio of 1.64. This is a normal value and indicates that TOM2 is financially healthy and should not expect problems in meeting its short term obligations.
TOM2's Current ratio of 1.64 is fine compared to the rest of the industry. TOM2 outperforms 67.96% of its industry peers.
TOM2 has a Quick Ratio of 1.60. This is a normal value and indicates that TOM2 is financially healthy and should not expect problems in meeting its short term obligations.
TOM2 has a better Quick ratio (1.60) than 68.93% of its industry peers.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 1.6
TOM2.AS Yearly Current Assets VS Current LiabilitesTOM2.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

3

3. Growth

3.1 Past

TOM2 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -15.70%.
TOM2 shows a decrease in Revenue. In the last year, the revenue decreased by -1.63%.
TOM2 shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.90% yearly.
EPS 1Y (TTM)-15.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-850%
Revenue 1Y (TTM)-1.63%
Revenue growth 3Y4.25%
Revenue growth 5Y-3.9%
Sales Q2Q%-3.93%

3.2 Future

The Earnings Per Share is expected to grow by 82.43% on average over the next years. This is a very strong growth
TOM2 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.40% yearly.
EPS Next Y35.71%
EPS Next 2Y124.41%
EPS Next 3Y82.43%
EPS Next 5YN/A
Revenue Next Year-2.92%
Revenue Next 2Y0.22%
Revenue Next 3Y1.45%
Revenue Next 5Y7.4%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
TOM2.AS Yearly Revenue VS EstimatesTOM2.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
TOM2.AS Yearly EPS VS EstimatesTOM2.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 -1 -1.5

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TOM2. In the last year negative earnings were reported.
TOM2 is valuated rather expensively with a Price/Forward Earnings ratio of 18.88.
Based on the Price/Forward Earnings ratio, TOM2 is valued a bit cheaper than 78.64% of the companies in the same industry.
TOM2's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.86.
Industry RankSector Rank
PE N/A
Fwd PE 18.88
TOM2.AS Price Earnings VS Forward Price EarningsTOM2.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, TOM2 is valued cheaply inside the industry as 82.52% of the companies are valued more expensively.
66.02% of the companies in the same industry are more expensive than TOM2, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 32.82
EV/EBITDA 9.31
TOM2.AS Per share dataTOM2.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as TOM2's earnings are expected to grow with 82.43% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y124.41%
EPS Next 3Y82.43%

More info and screens

0

5. Dividend

5.1 Amount

TOM2 does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TOMTOM NV

AMS:TOM2 (9/19/2025, 7:00:00 PM)

5.455

-0.1 (-1.8%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)07-15 2025-07-15
Earnings (Next)10-14 2025-10-14
Inst Owners15.18%
Inst Owner ChangeN/A
Ins Owners53.34%
Ins Owner ChangeN/A
Market Cap681.88M
Analysts45
Price Target5.48 (0.46%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2.38%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)58.62%
EPS NY rev (3m)58.62%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.87%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 18.88
P/S 1.2
P/FCF 32.82
P/OCF 16.43
P/B 5.7
P/tB N/A
EV/EBITDA 9.31
EPS(TTM)-0.26
EYN/A
EPS(NY)0.29
Fwd EY5.3%
FCF(TTM)0.17
FCFY3.05%
OCF(TTM)0.33
OCFY6.09%
SpS4.56
BVpS0.96
TBVpS-0.72
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.35%
ROE -25.67%
ROCE 0.16%
ROIC 0.12%
ROICexc 0.29%
ROICexgc N/A
OM 0.13%
PM (TTM) N/A
GM 87.37%
FCFM 3.65%
ROA(3y)-5.92%
ROA(5y)-10.94%
ROE(3y)-25.16%
ROE(5y)-35.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.86%
GM growth 5Y2.76%
F-Score6
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 1.98
Debt/EBITDA 1.18
Cap/Depr 77.01%
Cap/Sales 3.64%
Interest Coverage 0.31
Cash Conversion 150.18%
Profit Quality N/A
Current Ratio 1.64
Quick Ratio 1.6
Altman-Z 1.36
F-Score6
WACC7.55%
ROIC/WACC0.02
Cap/Depr(3y)20.27%
Cap/Depr(5y)16.21%
Cap/Sales(3y)1.63%
Cap/Sales(5y)1.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-850%
EPS Next Y35.71%
EPS Next 2Y124.41%
EPS Next 3Y82.43%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.63%
Revenue growth 3Y4.25%
Revenue growth 5Y-3.9%
Sales Q2Q%-3.93%
Revenue Next Year-2.92%
Revenue Next 2Y0.22%
Revenue Next 3Y1.45%
Revenue Next 5Y7.4%
EBIT growth 1Y102.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year88.57%
EBIT Next 3Y60.98%
EBIT Next 5YN/A
FCF growth 1Y241.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y642.03%
OCF growth 3Y-66.75%
OCF growth 5Y-57.16%